Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats

Liver

Volumn 21, Issue 6, 2001, Pages 405-409

  Castilla Cortázar, Inma ^a,b   Aurelia Aliaga Montilla, M ^a   Salvador, Javier ^a   García, María ^a,b   Delgado, Gloria ^b   González Barón, Salvador ^b   Quiroga, Jorge ^a   Prieto, Jesús ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Cirrhosis; GH regulation; GH IGF I axis; Somatostatin

Indexed keywords

CARBON TETRACHLORIDE; GROWTH HORMONE; PYRIDOSTIGMINE; SODIUM CHLORIDE; SOMATOMEDIN C; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; FEEDBACK SYSTEM; GROWTH HORMONE RELEASE; HORMONE INHIBITION; LIVER CIRRHOSIS; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; RAT STRAIN;

ADMINISTRATION, INHALATION; ANIMALS; CARBON TETRACHLORIDE; CHOLINESTERASE INHIBITORS; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PYRIDOSTIGMINE BROMIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC;

EID: 0035191992     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.210607.x     Document Type: Article

References (22)

1. Growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease
2. Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosis
3. Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis
4. Insulin-like growth factor-I: A good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis
5. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro
6. Cholinergic agonista, antagonist drugs modulate the growth hormone response to growth hormone releasing hormone in the ]rat: Evidence for mediation by somatostatin
7. Involvement of the somatostatin, cholinergic systems in the mechanism of growth hormone auto feedback regulation in the rat
8. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects
9. The role of the cholinergic pathway in growth hormone feedback
10. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: Combined administration of pyridostigmine and growth hormone-releasing hormone
11. Impaired intestinal sugar transport in cirrhotic rats: Correction by low doses of insulin-like growth factor I
12. Effect of insulin-like growth factor-I on in vivo intestinal absorption of D-galactose in cirrhotic rats
13. Low doses of Insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis
14. Hepatoprotective effects of Insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis
15. Osteopenia in rats with liver cirrhosis: Beneficial effects of IGF-I treatment
16. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis
17. Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats
18. Somatomedin C mediates growth hormone negative feed-back by effects on both the hypothalamus and the pituitary
19. Neuroendocrine regulation of growth hormone
20. Pyridostigmine-mediated growth hormone release: Evidence for somatostatin involvement
21. Hypothalamic regulation of impaired growth hormone secretion in diabetic rats
22. Evidence for autoregulation of growth hormone secretion via the central nervous system